BASILIO
COLLIGRIS
Investigador de proyecto específico
Argitalpenak (13) BASILIO COLLIGRIS argitalpenak
2023
2018
2017
-
The role and therapeutic potential of melatonin in age-related ocular diseases
Journal of Pineal Research, Vol. 63, Núm. 2
-
Therapeutic inhibitors for the treatment of dry eye syndrome
Expert Opinion on Pharmacotherapy, Vol. 18, Núm. 17, pp. 1855-1865
2014
-
An update on dry eye disease molecular treatment: Advances in drug pipelines
Expert Opinion on Pharmacotherapy, Vol. 15, Núm. 10, pp. 1371-1390
-
Dry eye disease compounds currently under evaluation in clinical trials
Anales de la Real Academia Nacional de Farmacia, Vol. 80, Núm. 1, pp. 151-178
-
Recent developments on dry eye disease treatment compounds
Saudi Journal of Ophthalmology, Vol. 28, Núm. 1, pp. 19-30
2013
-
Contact lenses: Promising devices for ocular drug delivery
Journal of Ocular Pharmacology and Therapeutics, Vol. 29, Núm. 2, pp. 189-199
-
Recent patents on Achondroplasia: Latest research development
Recent Patents on Regenerative Medicine, Vol. 3, Núm. 3, pp. 264-277
2012
-
Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential
Expert Opinion on Drug Discovery, Vol. 7, Núm. 10, pp. 989-1001
-
Potential role of Rho-associated protein kinase inhibitors for glaucoma treatment
Recent Patents on Endocrine, Metabolic and Immune Drug Discovery, Vol. 6, Núm. 2, pp. 89-98
-
Recent patents and developments in glaucoma biomarkers
Recent Patents on Endocrine, Metabolic and Immune Drug Discovery, Vol. 6, Núm. 3, pp. 224-234
-
Update in glaucoma medicinal chemistry: Emerging evidence for the importance of melatonin analogues
Current Medicinal Chemistry, Vol. 19, Núm. 21, pp. 3508-3522